Secondary Malignant Neoplasm — Trials

Secondary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,674 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,275
Recruiting: 2,321
Ph III recruiting: 270
Growth YoY: +12.6%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 451–500 of 1,225 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05770531	Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy	recruiting	Phase 2	160	Vanderbilt-Ingram Cancer CenterOTHER	1	Jun 24, 2026	clinicaltrials
NCT06835972	A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)	recruiting	Phase 1 / Phase 2	43	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 24, 2026	clinicaltrials